Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.
2.

Relative Contributions of Herpes Simplex Virus 1 ICP0 and vhs to Loss of Cellular IFI16 Vary in Different Human Cell Types.

Orzalli MH, Broekema NM, Knipe DM.

J Virol. 2016 Aug 26;90(18):8351-9. doi: 10.1128/JVI.00939-16. Print 2016 Sep 15.

4.

Characterization of Elements Regulating the Nuclear-to-Cytoplasmic Translocation of ICP0 in Late Herpes Simplex Virus 1 Infection.

Samrat SK, Ha BL, Zheng Y, Gu H.

J Virol. 2018 Jan 2;92(2). pii: e01673-17. doi: 10.1128/JVI.01673-17. Print 2018 Jan 15.

5.
6.

ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.

Halford WP, Weisend C, Grace J, Soboleski M, Carr DJ, Balliet JW, Imai Y, Margolis TP, Gebhardt BM.

Virol J. 2006 Jun 9;3:44.

7.
8.

A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence.

Boutell C, Cuchet-Lourenço D, Vanni E, Orr A, Glass M, McFarlane S, Everett RD.

PLoS Pathog. 2011 Sep;7(9):e1002245. doi: 10.1371/journal.ppat.1002245. Epub 2011 Sep 15.

9.

DNA sensing-independent inhibition of herpes simplex virus 1 replication by DAI/ZBP1.

Pham TH, Kwon KM, Kim YE, Kim KK, Ahn JH.

J Virol. 2013 Mar;87(6):3076-86. doi: 10.1128/JVI.02860-12. Epub 2013 Jan 2.

10.

Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection.

Eidson KM, Hobbs WE, Manning BJ, Carlson P, DeLuca NA.

J Virol. 2002 Mar;76(5):2180-91.

11.

Identification of TRIM27 as a novel degradation target of herpes simplex virus 1 ICP0.

Conwell SE, White AE, Harper JW, Knipe DM.

J Virol. 2015 Jan;89(1):220-9. doi: 10.1128/JVI.02635-14. Epub 2014 Oct 15.

12.

A proteomic perspective of inbuilt viral protein regulation: pUL46 tegument protein is targeted for degradation by ICP0 during herpes simplex virus type 1 infection.

Lin AE, Greco TM, Döhner K, Sodeik B, Cristea IM.

Mol Cell Proteomics. 2013 Nov;12(11):3237-52. doi: 10.1074/mcp.M113.030866. Epub 2013 Aug 12.

13.
15.
16.
17.

Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.

Diner BA, Lum KK, Javitt A, Cristea IM.

Mol Cell Proteomics. 2015 Sep;14(9):2341-56. doi: 10.1074/mcp.M114.047068. Epub 2015 Feb 18.

18.

Selective ablation of virion host shutoff protein RNase activity attenuates herpes simplex virus 2 in mice.

Korom M, Wylie KM, Morrison LA.

J Virol. 2008 Apr;82(7):3642-53. doi: 10.1128/JVI.02409-07. Epub 2008 Jan 30.

19.

Cell-type-specific effects of RNase L on viral induction of beta interferon.

Banerjee S, Chakrabarti A, Jha BK, Weiss SR, Silverman RH.

MBio. 2014 Feb 25;5(2):e00856-14. doi: 10.1128/mBio.00856-14.

20.

CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β.

Smith MC, Bayless AM, Goddard ET, Davido DJ.

Antiviral Res. 2011 Sep;91(3):259-66. doi: 10.1016/j.antiviral.2011.06.009. Epub 2011 Jun 22.

Supplemental Content

Support Center